BridgeBio Oncology Therapeutics (BBOT) Q3 2025 Earnings

1AugConfirmed
Q3 2025
-49.62
-47.23
-44.84
-42.45

Details

Expected EPS
-42.45
Actual EPS
-49.615
Surprise EPS
-7.16
Surprise Percent
+16.88%

Description

BridgeBio Oncology Therapeutics (BBOT) has reported earnings of -49.615 per share for Q3 2025.

0 Comments

Share your thoughts